Pulmonary function is better preserved after LC than after OC.
Increasing gap between demand and availability of human kidneys for transplantation has forced a re-evaluation of the limits on donor age acceptability. e present study included patients who underwent kidney transplantation in University Clinical Centre Tuzla. In an observational cohort study we assessed impact of donor age on post transplant renal function by analyzing following parameters: hour urine output, creatinine clearance (Cr Cl) and glomerular fi ltration rate (GFR). Depending on donor age recipients were allocated in to two groups. Group I included patients who received renal graft from donors age up to years, and Group II encountered recipients who received renal graft from donors older than years. Our goal was to determine whether donor age over years signifi cantly diminishes renal graft function in fi rst seven post transplant days. No statistically signifi cant diff erence was found between Group I and II regarding hour urine output. From second to fi fth postoperative day creatinine clearance values were higher in the group of patients who received kidney from donors older than years (±, vs. , ±, ). On the fi fth, sixth and seventh post operative day GFR was signifi cantly higher in patients who received renal graft from donors age up to years (p<, ). Our data showed no signifi cant diff erence in observed variables between the two groups, thus indicating that utilization of renal grafts from donors' age > years is acceptable and may considerably expand the donor pool.
All conventional immunosuppressive tree drugs-protocols are based on Cyclosporine; consisting of low doses of Cyclosporine (CsA), Azathioprine (AZA) or Mycophenolate Mofetil (MMF) and Prednisolone. AZA has been used in clinical transplantation for more than years and was the fi rst immunosuppressive agent to achieve widespread use in organ transplantation. MMF was introduced in clinical practice in after several clinical trials proved that it was more effi cient than AZA for prevention of acute rejection episodes. Our aim was to evaluate infl uence of AZA and MMF on renal graft function in early post-transplant stage. Study recruited patients who underwent kidney transplantation in University Clinical Centre Tuzla. All patients received CsA and corticosteroid-based immunosuppression, as a part of triple immunosuppressive regiment, patients received AZA and MMF. In order to assess renal graft function, following parameters were evaluated: glomerular fi ltration rate GFR (ml/min) creatinine clearance (CrCl) (ml/min), h urine output (ml/day), and from the serum potassium, sodium, urea and creatinine (mmol/dm). Signifi cantly higher average values of hour urine output were recorded during fi rst seven postoperative days in patients receiving MMF compared to those treated with AZA. Serum creatinine values showed statistically signifi cant decrease, starting with the second postoperative day, in MMF vs. AZA group (,±, vs. ,±,; p<,). GFR was signifi cantly higher in MMF compared to the AZA group of patients. On the fi rst post-transplant day CrCl was higher in AZA group (,± vs. ,±,; p=,), next six days situation is reversed CrCl is signifi cantly higher in the MMF group (,± vs. , ±, p=,). MMF vs. AZA therapy was associated with protective eff ect against worsening of renal function in fi rst seven post-transplant days.
<p><strong>Background:</strong> Many efforts have been made to find diagnostic tools that would help select children with clinical signs of acute appendicitis that would need immediate appendectomy and to find tools that would reduce the numbers of negative appendectomies.</p><p><strong>Aim:</strong> We aimed to show the association between leukocyte count, level of C-reactive protein and interleukin-6 in peripheral blood on the one side and the degree of histological findings on appendix after appendectomy on the other side in children with high clinical probability for appendicitis (Alvarado score>7).</p><p><strong>Methods:</strong> We analyzed 80 patients of both genders, younger than 15 years, with Alvarado score>7, which underwent open appendectomy with subsequent histological analysis of removed appendices. We sampled 20 consecutive cases without signs of inflammation (group I), 20 cases with pathological signs of incipient inflammation (group II), 20 cases with signs of phlegmonous inflammation (group III) and 20 cases with signs of perforated appendix (group IV). Prior to appendectomy, a peripheral blood was sampled and sent for analysis of leukocyte count and C-reactive protein and interleukine-6 level. We compared values of all 3 measured parameters according to histological findings; we also used Receiver Operating Characteristics (ROC) analysis in order to evaluate diagnostic thresholds for detecting the histological signs of appendicitis.<strong> </strong></p><p><strong>Results:</strong> The lowest values of all observed parameters were found in group of negative appendicitis while highest were observed in the group of perforated appendicitis. We have observed a significant between group differences in values of all three parameters according to the degree of histological inflammation (p<0.001). ROC analysis demonstrated that interleukine-6 had the best diagnostic performance in detecting patients with histological signs of appendicitis (AUROC=0.99; 95% CI=0.99-1.00) when compared to CRP and leukocyte count (p<0.05). There was no significant difference in diagnostic performance between CRP and leukocytes counts (p=0.35).</p><p><strong>Conclusion:</strong> Leukocyte count, CRP and interleukine-6 are very useful markers which may help in diagnostics and differentiation of phlegmonous and perforated appendicitis. In patients with high probability of appendicitis, measurement of interleukine-6 may help in better patient selection.</p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.